Leprosy in the Global Middle Ages: A Slow Pandemic

In August 2024, Jordan became the first country to officially eliminate leprosy.1 Countries participating in the World Health Organization (WHO)2 have committed not simply to bringing percentages of leprosy infections down, but to “getting to zero” in terms of absolute numbers of disease transmissions, all the while upholding the dignity of those who suffer from what can be a severely debilitating condition. The complete elimination of leprosy globally is the goal.

Is that even possible? The WHO’s 2024 global report on leprosy gathers data from 184 countries. 56 countries reported 0 cases of leprosy in 2023, the long-term consequence of declining incidence of the disease over the past century, thanks in large part to the antibiotic therapies available since the 1990s. Nevertheless, the same report counts 172,570 people worldwide currently afflicted with this now-curable disease, with 182,815 newly detected cases during the 2023 year. The 128 countries still reporting leprosy comprise all five inhabited continents. Leprosy is still a global disease.

A map of the world

AI-generated content may be incorrect.
A map of the geographic distribution, and levels of prevalence, of leprosy throughout the world, as of 2023. Source: WHO 2024.

But when did leprosy become “global”? And how might answering that question help us better understand the challenges involved in eliminating it? Neither as eternal as often assumed nor the result of globalizing forces in the modern era, leprosy as a human disease seems to be only about 5-6000 years old. Humans had globalized—moved into the five inhabited continents—long before that. But leprosy, it seems, did not initially travel with them. The genetic footprint for leprosy’s history suggests that it may have originated as a human disease somewhere near the Pacific Rim of Asia, and spread slowly from there. In the last 2000 years, however, it has diverged wildly, moving across continents and into new ones. Its almost complete globalization dates from the Middle Ages. 

A graph showing a line of a graph

AI-generated content may be incorrect.
An estimate of the effective population size of M. leprae infections over the course of the last 3000 years, based on its increasing genetic diversity. Reading right-to-left, the two major periods of expansion were the early Middle Ages and the period of global colonialism (and slavery) after 1500. Source: Pfrengle et al. 2021, fig. 3.

Which is why our North Africa-to-Italy transplant, Constantine the African (d. before 1098/99), makes an excellent focal point for thinking about leprosy’s past as well as its future. Constantine’s linking of Tunisia and Italy—across the “middle of the Middle Sea” (the Mediterranean)—parallels his chronological situation in the middle of leprosy’s medieval globalization. The accelerating long-distance trade that made his distantly-sourced pharmacopeia available also caused humans themselves to be carried across continents and oceans. (Sometimes willingly; sometimes not.) Leprosy traveled with them. Constantine could never have known it, but within about 200 years of when he was writing, leprosy had likely made its way more than halfway across the Pacific, all the way to Hawai’i. Humans carried it, but what likely helped it persist in its new environs were local animal populations. And we have seen in recent years, human-animal interfaces can be at the heart of what fuels pandemics.

Constantine as Mediator: Leprosy in the Medieval Mediterranean

In last year’s post for World Leprosy Day, we saw that Constantine had written a specialized text on this disease without stigmatizing it or its sufferers. But the crowning work of his career was translating the better part of a massive medical encyclopedia from Arabic, the Kitāb al-Malakī (Book of the King) composed by the Persian physician ʿAlī ibn al-ʿAbbas al-Majūsī by 977/78. In the chapter he devotes to the causes and symptoms of leprosy, Constantine deliberately omits al-Majūsī’s characterization of leprosy as a “cancer affecting the whole body.” Although he retains al-Majūsī’s suggestion that leprosy is contagious and that healthy people would be wise to avoid close contact with those infected, his discussion is free of any moralizing. In fact (as medical historian Anna Gili notes), it was not fear of contagion that prompted the expanding foundation of leprosaria throughout Europe in the 11th and 12th centuries, but changes in social concerns about how those most in need of aid should be cared for.

Evidence of Acceptance: Letting the Bones Tell New Stories

The possibility that care rather than scorn was the initial motivator for the European push to found leprosaria can now be seen from physical evidence as well. For the past decade, paleogeneticists and bioarchaeologists have been reconstructing the physical history of bodies afflicted by the bacteria that cause leprosy. In a new study on the cemetery of Sant Llàtzer in Barcelona, the first excavated cemetery in Spain directly linked to a leprosarium, a team of bioarchaeologists and historians have investigated both the thoughts and actions of a community’s responses to leprosy.

Used between the 12th and the 18th centuries, the leprosarium of Sant Llàtzer lay at the intersection of two roads leading to the city gates, just outside the city walls amid orchards and vineyards. Later, when the city expanded, the leprosarium was enclosed within the walls. Thus, there was nothing exclusionary in the placement of the house. Bioarchaeological analysis of remains from the in-house cemetery demonstrate that a number of those buried there did indeed bear all the hallmarks of extensive leprosy infections. Radiocarbon-dating of one such individual, whose hands show the characteristic “pencilling” or bone erosion common in leprosy, indicates that she lived at some point between 1038 and 1179; thus, she may have been a near-contemporary of Constantine the African. 

A comparison of bones and a size comparison

AI-generated content may be incorrect.
A photograph and an X-ray of the finger bone of an 11th– or 12th-century woman afflicted by leprosy, found in the cemetery of Sant Llàtzer in Barcelona. Source: Montes et al. 2025, fig. 6.

In what’s called a “life-course approach”—which looks at physical evidence to reconstruct how a person lived, rather than just how they died—the bioarchaeologist Alette Blom has found that physical hardship in childhood (poor nutrition, stresses from other infectious diseases) primed the leprosy-infected for severe effects of leprosy later in life. That situation, in turn, made it more likely that individuals would need the long-term care in daily living that leprosaria provided.

Such approaches tell the story of individuals. How can we broaden our focus to tell about pandemics? First of all, accumulating data from genetics is already revealing the astounding breadth and complexity of the bacterium’s travels. As already noted in 2022, the strain of M. leprae that now finds major distribution in West Africa may have entered the continent through ancient Egypt. And we find an almost mirror-image of strain distribution in modern Brazil, following patterns of transatlantic slavery after 1500 CE. 

As so many clues to the path of leprosy’s spread get filled in, it becomes increasingly urgent to ask how the disease has persisted. In 2014, an odd discovery was made. Squirrels in present-day Scotland were found to be infected with leprosy. Could squirrels have been an element in the medieval transmission of leprosy, too? And if so, in which direction: were they bringing leprosy to humans, or “catching” it from humans with whom they were interacting? 

That lucky find of leprosy in squirrels (more has since been documented) combined with some deep sleuthing has shown how important the new One Health conception of disease history is. The concept of One Health looks at (among other things) disease transmission across host species. The most recent work on this question detected molecular fragments of M. leprae in squirrel remains coming from medieval Winchester. Comprehensive scouring of historical documents and manuscript images then reconstructed how people in medieval Europe interacted with squirrels. The answer was: a lot! They used them extensively for fur trimming on their clothes. And they even kept them as pets. 

Add_ms_42130_f033r_detail
A lady with a pet squirrel, Luttrell Psalter, ca. 1320-1340 (England). Source: London, British Library, MS Additional 42130, f. 33r.

All this documented interaction means that, at the moment, there is no way to tell which direction leprosy was being transmitted: was it from humans to squirrels, or squirrels to humans? But it does tell us that the strains of M. leprae still found in wild squirrel populations in the UK are living traces of interactions 100s of years ago. 

Leprosy as a Slow Pandemic 

The COVID-19 pandemic underscored our sense that pandemics are rapid, sudden, inexplicable transmissions of disease through vast swathes of human populations. Yet we can think of leprosy’s global distribution as a pandemic, too, even though it happened over the course of centuries rather than weeks or months. It happened without the airplanes that made COVID’s global spread possible, and without the steamships that carried the 1918 Flu around the world. It happened without the railroads and major canals that made the early 19th-century cholera pandemics possible. Rather, leprosy’s pandemic shows us the paths of humanity’s most adventurous expansions in the days of sail. The global map of leprosy that George Thin published in 1891 is nothing other than a snapshot of this pandemic’s long-term effects.

A map of the world with red spots

AI-generated content may be incorrect.
A map of the global distribution of leprosy, prepared by George Thin in 1891. Source: Wellcome Library (via Wikimedia).

One of the most tragic stories of persons suffering from leprosy is the enforced segregation in the Hawai’ian settlement of Kalaupapa in the later 19th and 20th centuries. But exactly when did leprosy arrive in the Pacific? A study completed in 2024 found that, as had already been hinted in 2020, the strains of leprosy in Hawai’i and other Pacific Islands belonged to the most ancient lineages of Mycobacterium leprae from the Pacific Rim and may have been brought to the islands by their first human inhabitants. Since Hawai’i, the easternmost island group of Polynesia, has been inhabited since around 1250, that means that leprosy had nearly circumnavigated the globe within 150 years of Constantine’s lifetime.

The biggest remaining mystery about leprosy’s medieval history is whether it had reached the Americas before contact with Europeans and Africans starting in 1492. This part of the story involves the recently discovered species of leprosy, Mycobacterium lepromatosis. This is in fact the species of leprosy that was found in squirrels in the UK in 2014. That strain seems far distant, however, from the strains now afflicting humans on the other side of the world in the Americas, where M. lepromatosis was first discovered in 2008.3 M. lepromatosis has also been confirmed in Southeast Asia, including India.

Yet unlike the “classic” leprosy, M. leprae, for which 100s of complete genome sequences are now available, allowing the creation of a rich family tree of the organism’s evolution, only three complete genome sequences are currently available for M. lepromatosis. Only one of them is of high quality. At the moment, the American strains seem to be quite closely related to each other, suggesting their dispersal in the region only in the past couple hundred years. But where did they come from? As a recent clinical report on M. lepromatosis in the American Midwest noted, “The geographic reach of this disease may be much broader than previously thought.” 

In 2021, a ten-year plan, the Global Leprosy Strategy called “Towards Zero Leprosy,” began. The likely role of squirrels in leprosy’s medieval transmission between humans and animals parallels the documented role of armadillos in the Americas, which have been connected to both M. leprae and M. lepromatosis. If cross-species transmission is (and maybe, has always been) the norm for this disease, how will the world get to “zero”? Interrogating the medieval history of leprosy will not answer that question directly. But it will show us why it is a necessary question to ask. Seeing leprosy as a “pandemic in slow motion” shows us the value of framing pandemic research in a One Health framework.


1. Jordan’s achievement was not to be the first country to have zero reported leprosy cases, but to be the first to have systematically eliminated the disease by following a prescribed public health framework and received verification. See https://www.who.int/news/item/19-09-2024-jordan-becomes-first-country-to-receive-who-verification-for-eliminating-leprosy

2. As of 20 January 2025, that group no longer includes the United States of America, which has withdrawn from the World Health Organization but which reported 369 cases of leprosy for 2023; source: WHO 2024.
3. As an increasing body of literature is compiled on Mycobacterium lepromatosis, it seems that this species of leprosy manifests somewhat differently than its cousin, M. leprae, in terms of symptoms and speed of morbid effects. However, the only way to distinguish the two definitively is by molecular analysis, which has only been available in recent years. Thus even though M. lepromatosis was only discovered in 2008, it is in no way a “new” disease. See Collin et al. 2023 for current information on its geographic extent.


Select bibliography:

Collin, Simon M., Amanda Lima, Stéfano Heringer, Vinícius Sanders, Hugo Aborghetti Pessotti, Patrícia Deps. “Systematic Review of Hansen Disease Attributed to Mycobacterium lepromatosis,” Emerging Infectious Diseases 29, no. 7 (July 2023), 1376-1385.

Crane, Adele E. “Phylogenomics and Zoonotic Spillover of Mycobacterium leprae in the Pacific Islands and Brazil,” PhD diss., Arizona State University, 2024. https://keep.lib.asu.edu/items/195249

Gili, Anna. “Leprosy (al-ǧuḏām) and Smallpox (al-ǧudarī) in the Kitāb al-Malakī and its Two Latin Translations,” Medical and Philosophical Perspectives on Illness and Disease in the Middle Ages, a special issue of Quaderni di Noctua 7 (2024), ed. Alessandro Palazzo and Francesca Bonini, pp. 70-107.

Green, Monica H. [untitled: tweetstream on new leprosy phylogenetics study (Benjak et al 2018), in honor of World Leprosy Day 2018], archival copy posted on Academia.edu: https://www.academia.edu/118718902/ 

Green, Monica H. [untitled: Twitter thread on leprosy genetics, 2018-2022], collected tweets posted on Academia.edu, https://www.academia.edu/127132649/

Green, Monica H. “World Leprosy Day 2023: Hansen’s Disease, Han’s Disease, and the Global History of Leprosy,” a Twitter essay on the history of leprosy, to commemorate World Leprosy Day, 29 January 2023, https://www.academia.edu/95928220/.

Green, Monica H. “The Stigma of Neglect: Why We Know Less Than We Should About Medieval Leprosy,” Constantinus Africanus blog, 28 Jan 2024, https://constantinusafricanus.com/2024/01/28/the-stigma-of-neglect-why-we-know-less-than-we-should-about-medieval-leprosy/

Green, Monica H., and Jonathan Hsy. “Disability, Disease, and a Global Middle Ages,” in: Teaching the Global Middle Ages, ed. Geraldine Heng, MLA Options for Teaching (New York: PMLA, 2022), pp. 302-14.

Montes, Núria, Clara Jáuregui, Rosa Dinarès, Vanesa Triay, Andrea Fernández-Vilela, Jordi Ruiz, M. Eulàlia Subirà, and Maria Fontanals-Coll. “Tracing Leprosy: The Paleopathological Study of the Individuals Excavated from the Sant Llàtzer Leprosarium in Barcelona, Spain (12th-18th c.),” International Journal of Paleopathology 48 (March 2025), 23-33, https://www.sciencedirect.com/science/article/pii/S1879981724003267

World Health Organization (WHO). “Global leprosy (Hansen disease) update, 2023: Elimination of leprosy disease is possible – Time to act!,” Weekly Epidemiological Record (WER) 99, no. 37 (13 September 2024), 497–521.

The Stigma of Neglect: Why We Know Less Than We Should About Medieval Leprosy

A Post in Honor of World Leprosy Day 2024

An image from a medieval manuscript, showing a large initial “O” in red, with Latin text following it. The manuscript is owned by the Convent of St Francis of Assisi. Source: Assisi, Biblioteca del Convento di S. Francesco, MS 573, f. 115r.
Opening of the text of Constantine the African’s De elephancia (On Leprosy), in a recently discovered later 12th-century manuscript. Assisi, Biblioteca del Convento di S. Francesco, MS 573, f. 115r.

We don’t know exactly when Constantine the African wrote his treatise on leprosy, De elephancia (and yes, the ancient Greek name for the disease means exactly what it looks like: “the elephant disease”). Nor, in the absence of a dedicatory prologue (which we do have for some of his other texts), can we say whether this short, 11th-century Latin treatise was a “bespoke” production, prepared for a particular person or situation. 

Yet given our modern image of medieval Europe as a landscape riddled with leprosy, and given the extraordinary medieval popularity of many of Constantine’s other works (some of which survive in more than 100 copies), the existence of only ten independently circulating copies of Constantine’s leprosy text is puzzling. Something doesn’t sync.

The last Sunday of January every year is designated World Leprosy Day. It is meant to acknowledge the fact that leprosy (“Hansen’s Disease”) still exists, even though effective treatments to cure the condition have been available for several decades. The theme for World Leprosy Day 2024 is “Ending Stigma, Embracing Dignity.” Stigma is a very real factor in the continued prevalence of leprosy. As many as 200,000 people per year are newly diagnosed and many are successfully cured, yet public shame and social shunning still make many who are afflicted reluctant to seek out diagnosis and care. In other words, we should put as much effort into understanding why stigma persists as we do investigating the pathogen’s evolutionary history or its potential animal or environmental reservoirs.

As we commemorate World Leprosy Day this year, we might think about what it means that close to 950 years after its composition, we still have gaps in our knowledge not simply about the author of the De elephancia—the Arabic-speaking North African emigré, Constantinus Africanus, who died before 1098/99—but also about the text’s original users and its significance as a sophisticated piece of medical writing. What did it mean that one of the most influential Benedictine writers of the Middle Ages had written a specialized text on this disease, without stigmatizing it or its sufferers, but rather treating it as natural condition meriting natural interventions? 

The Character of the Text

In Latin, the De elephancia is just under 2600 words. Just a bit longer than this blogpost. Less than a full page in some finely-written manuscript copies. Yet it is longer than the attention Constantine gives to leprosy in his other works where he discusses the disease: the theoretical half of the Pantegni, a major encyclopedia of medicine, or the Viaticum, a “handbook for travelers.”

The opening of the text of Constantine the African’s De elephancia (On Leprosy), showing a handwritten manuscript page and a large initial letter ‘Q’ with filigree in red and blue ink. Source: Würzburg, Universitätsbibliothek, m. p. med. f. 3, f. 183r (detail).
In this mid-13th century copy of the De elephancia, made in southern France, the text takes up less than one page. Würzburg, Universitätsbibliothek, m. p. med. f. 3, f. 183r (detail).

Constantine’s assessments of leprosy, here in the De elephancia and in the Viaticum, convey the same theoretical understanding of the disease, one that had not previously been found in Latin medical writings. That is, that the disease is fourfold in nature, stemming from differences that arise depending on which of the four humors is defective. He begins the De elephancia thus:

It behooves the physician to investigate the putrefaction of the chyme, from which are born the four humors, along with their natures, which are either simple or complex. The cause of the putrefaction can come either from the corruption of the semen (of the male or the female),1 or from both, or from the corruption of the air, or food and drink. From these corrupt humors arises the infirmity, which is customarily called elephantia.2 The discernment of this condition is difficult and laborious in its early phases. But after it becomes openly apparent, this disease is harder to treat.

MF, p. 74

Constantine then goes on to specify the symptoms that characterize each of these four kinds of leprosy. Then, he introduces their names:

When the disease arises from blood, it is called alopicia. When instead it is created by red bile, it is named leonina. If from black bile, it is called elephantia. If from phlegm, it is called tiria.

MF, p. 80

Treatments—involving phlebotomy or cupping, purgatives, diet, eye washes, and astringents to treat the pustules, and ointments to soothe the skin—are then laid out. All are very detailed and precise, down to the amounts of individual ingredients. Take, for example, this unguent:

This unguent cleanses the whole body of putrefaction:Take three ounces of litharge [lead oxide], two ounces each of alum and quicksilver, two drams each of roses and white lead, three and a half drams each of savin, liquid storax, cadmium, one ounce each of the ashes of mastic and vitriol. Let all these be mixed with the juice of myrtle fruit, which is then cooked down until only one-third remains, and add rose oil as needed. Then, anoint the body with this for seven days; on the eighth day, [anoint just] with rose oil. On the ninth day, [anoint] with vinegar of wild grapes. On the tenth day, let the patient bathe.

MF, p. 88

Any dermatologist reading these instructions is probably cringing, because these are powerful chemicals; several have long since been banned from medicinal use. But for many centuries, such powerful astringents and corrosives were used to treat skin conditions. What is notable here is that after the week-long regimen of corrosives, there was an ameliorating healing regimen of oil, then vinegar, and then simple bathing in water. 

Other sections of the text draw on a complicated polypharmacy that, in the context of 11th-century southern Italy, would have assumed a certain wealth of its users. And that is one of the clues that prompts us to ask: was this text bespoke?

The Author and His Audience

As noted, the work has no dedicatory preface to tell us for whom it was made, nor to explain the author’s intentions. In fact, it is almost certain that we really shouldn’t be calling Constantine “the author.” It is well known that Constantine functioned primarily as a translator, rendering Arabic works into Latin (mostly by writers from North Africa, whence he came—and whence the epithet Africanus). The De elephancia, too, may have been a translation, likely of one of Constantine’s most frequent sources, the Qayrawan author, Ibn al-Jazzār (d. ca. 979).

We know that, eventually, after his arrival in southern Italy, Constantine was well supported by grants and donations from the local nobility and church leaders to render such works of Arabic medicine into Latin.3 While we don’t know the exact order of most of his compositions, it is likely that De elephancia was one of his earlier translations, perhaps coming before his De stomacho (On the Stomach), written for an archbishop of Salerno who had patronized him before dying in 1085, and the Pantegni, written for his abbot at Monte Cassino, who became pope that same year. 

As with the archbishop and his stomach problems, it’s possible that the patronage Constantine received came from his ability to produce bespoke works for particular clients. One such potential local “client” who was manifesting leprosy symptoms around this time, and whose family would have had the wealth to obtain expensive ingredients, was an elder (and illegitimate) son of Count Roger I, who reigned as count of Sicily from 1072 until his death in 1101. A recent study by historian Dawn Marie Hayes has established that this son was afflicted with leprosy, throwing his ability to inherit into doubt. 

As Hayes observes, the father, Roger, seems to have done whatever he could to help his son, including founding two monasteries that, both in their religious associations and in their physical locations, seem to have been strongly associated with leprosy and its treatment. Given the patronage the Normans gave Constantine, commissioning a bespoke treatise from the star medical scholar at Monte Cassino would be an obvious course of action. 

We don’t have the Arabic original that Constantine was using to write the De elephancia, so we cannot know if or how he adapted his source. As we have it now, there is nothing about this text to suggest that leprosy was a stigmatized disease. The very fact that Constantine (or his source) has distinguished different types of the disease, recognized the kinds of symptoms that create pain or discomfort, and developed complex therapies to address them—all signal, not stigma, but attentive care. 

The Impact of the De elephancia

If, as seems possible, the De elephancia came from a privately motivated impetus, that may explain why it remained closely associated with Constantine’s other specialized texts: his treatise on the stomach (also bespoke), a work on diseases of the eyes, another on depression. To the ten surviving independently circulating copies of the De elephancia, we can add two more “witnesses”: references to the text in library inventories. In ten of those twelve cases, the De elephantia (also called De lepra) appears in collections of Constantine’s works. For example, De lepra is listed among a major collection of medical books owned in the middle of the 12th century by the bishop of Hildesheim, Bruno (d. 1161).

The first of two images from two medieval manuscripts. On the left, a manuscript page including the words in red, “Incipit liber elefantie” (Here begins the Book on Leprosy). On the right, a neatly written manuscript page with a red arrow and underlining flagging the words “Liber de lepra” (Book on Leprosy). Sources: Cambridge, Gonville and Caius College, MS 411/415, f. 109v; and Paris, Bibliothèque de la Sorbonne, MS 636, f. 26v.The second of two images from two medieval manuscripts. On the left, a manuscript page including the words in red, “Incipit liber elefantie” (Here begins the Book on Leprosy). On the right, a neatly written manuscript page with a red arrow and underlining flagging the words “Liber de lepra” (Book on Leprosy). Sources: Cambridge, Gonville and Caius College, MS 411/415, f. 109v; and Paris, Bibliothèque de la Sorbonne, MS 636, f. 26v.
Witnesses to Constantine’s De elephantia, both surviving and lost: on the left, a copy now in Cambridge, Gonville and Caius College, MS 411/415, f. 109v; on the right, a page describing a medical volume owned by the French physician and cleric, Richard de Fournival (d. 1260), Paris, Bibliothèque de la Sorbonne, MS 636, f. 26v.

Besides whatever circulation this tiny text may have had on its own (it might, for example, have been included with a letter of advice, and we’d never have any trace of it), it also had a secondary life that made it a permanent fixture in European learned medicine. The De elephancia was incorporated wholesale into the Practica of the Pantegni, when some unknown editor “re-created” that previously lost second half of Constantine’s encylopedia sometime in the 12th century. And that encyclopedia—now made whole—appeared as a fixture in religious and university libraries all over Europe.4

Leprosy and Stigma
The most recently discovered manuscript of the De elephancia is the one shown at the opening of this post. It is now held in a library in Assisi, Italy. If “Assisi” sounds familiar to you as a city associated with leprosy, then you know your history well. Saint Francis of Assisi (born ca. 1180, died 1226) may have been alive when this manuscript was made, sometime in the second half of the 12th century. We don’t know that it was made for him or any of his followers, nor how it came to reside in the convent’s library.

A photo of the courtyard of a large building, with porticos. Source: https://upload.wikimedia.org/wikipedia/commons/e/e8/%22_Basilica_di_San_Francesco_%28Assisi%29_Sacro_Convento_%22.jpg.
Photo of the courtyard of the Franciscan Convent in Assisi. Source: https://upload.wikimedia.org/wikipedia/commons/e/e8/%22_Basilica_di_San_Francesco_%28Assisi%29_Sacro_Convento_%22.jpg

We do know, however, that care of leprosi—persons suffering from leprosy—came to be a main task of the Franciscans. Indeed, we have reason to think the Francis himself was afflicted by the disease, and disabled by it.5

What does a nearly 1000-year-old leprosy text have to add to interventions to deal with this disease now? The concerns of the international agencies involved in leprosy research and public health are necessarily focused on leprosy in the present day, and disrupting its ability to inflict future damage on human populations. New drugs, new therapeutic interventions, new mechanisms to detect prevalence and modes of transmission—these are all urgent concerns. Yet the concern for stigma goes beyond chemistry or genetics and gets us back to culture.

Yes, we are learning a lot about Constantine, thanks to work of such skilled young scholars as Brian Long, Outi Kaltio, and Anna Gili. And yes, we have learned much about the persecutions of “lepers” in southern France in the early 14th century from the recent researches of the historian, Tzafrir Barzilay. But we cannot yet say whether shifting ideas about leprosy per se played a role in violently compromising the culture of institutional care that had developed for over two centuries in medieval Europe. It is important for us to consider how stigma is transmitted, and recognize that it is not a universal constant. 

Constantine’s De elephancia carries no opprobrium about the disease, even as it recognizes the physical symptoms it causes. Leprosy may be a “neglected” disease now, but that neglect is on us, not the past.

This essay is dedicated to the several hundred members of the MEDMED community, an online forum that, for the past fifteen years, has been “modelling good behavior” in combining capacious curiosity, methodological rigor, and scholarly generosity. Grazie mille especially to Iolanda Ventura, who brought the Assisi manuscript to my attention.

Notes

1.  In the medieval Galenic system, the gonads of both the male and female were thought to produce semen, ejaculated during sexual intercourse.

2. All quotations from the De elephancia draw on Martín Ferreira’s 1996 edition (hereafter MF), as well as my own consultation of the earliest manuscripts. In the two oldest extant copies of the De elephancia, Brussels, KBR, MS 14322-23 and Munich, BSB, Clm 23535, as well as the late 12th-century copy, Assisi 573, elephantia appears in this passage as the standard name for the disease. In the later 12th-century English manuscript, Cambridge, Gonville & Caius College, MS 411/415, however, lepra appears, as it does in most later copies and in the Renaissance printed editions.

3. On Constantine’s networks of support, see Kwakkel and Newton 2019.

4. Most recently on the Pantegni’s circulation, see Gili 2023.

5. See Trembinski 2020.

Further Reading:

Gili, Anna. “I Codici della Pantegni tra tradizione e innovazione,” Gazette du livre médiéval, no 67 (2021-2023), 37-63.

Green, Monica H. “Medicine in France and England in the Long Twelfth Century: Inheritors and Creators of European Medicine,” in: France et Angleterre: manuscrits médiévaux entre 700 et 1200, ed. Charlotte Denoël and Francesco Siri, Bibliologia 57 (Turnhout: Brepols, 2020), pp. 363-388.

Green, Monica H. “An Essay for World Leprosy Day 2020: Leprosy’s Medieval History and What We Can Learn from It Today,” Twitter, 26 January 2020, posted on Academia.edu, https://www.academia.edu/44229146

Hayes, Dawn Marie. “The Case of Geoffrey of Hauteville, Lord of Ragusa: A Story of Leprosy and Legitimacy from Norman Sicily,” Speculum 98, no. 1 (Jan 2023), 86-121.

Kwakkel, Erik, and Francis Newton. Medicine at Monte Cassino: Constantine the African and the Oldest Manuscript of His ‘Liber Pantegni’ (Turnhout: Brepols, 2019).

Martín Ferreira, Ana Isabel, ed. Tratado médico de Constantino el Africano: Constantini Liber de elephancia ([Valladolid]: Universidad de Valladolid, 1996).

Trembinski, Donna. Illness and Authority: Disability in the Life and Lives of Francis of Assisi (Toronto: University of Toronto Press, 2020).